Syra Health Corp. Class A Common Stock (SYRA)
USD 0.38
(-3.8%)
USD 0.38
(-3.8%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.29 Million USD | 36.43% |
| 2022 | 3.15 Million USD | 626.76% |
| 2021 | 433.63 Thousand USD | 10062.5% |
| 2020 | 4267.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 875.92 Thousand USD | -44.75% |
| 2024 Q3 | 1.09 Million USD | 25.26% |
| 2024 Q1 | 1.58 Million USD | 1.1% |
| 2023 Q1 | 907.66 Thousand USD | 2.54% |
| 2023 Q4 | 1.56 Million USD | 74.72% |
| 2023 FY | 4.29 Million USD | 36.43% |
| 2023 Q3 | 897.55 Thousand USD | -1.6% |
| 2023 Q2 | 912.11 Thousand USD | 0.49% |
| 2022 Q1 | 541.53 Thousand USD | 0.0% |
| 2022 FY | 3.15 Million USD | 626.76% |
| 2022 Q4 | 885.18 Thousand USD | 17.13% |
| 2022 Q3 | 755.73 Thousand USD | 95.34% |
| 2022 Q2 | 386.87 Thousand USD | -28.56% |
| 2021 FY | 433.63 Thousand USD | 10062.5% |
| 2020 FY | 4267.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 97.557% |
| Addus HomeCare Corporation | 248.92 Million USD | 98.273% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 96.366% |
| Amedisys, Inc. | 834.47 Million USD | 99.485% |
| American Oncology Network, Inc. | 83.97 Million USD | 94.88% |
| Astrana Health, Inc. | 112.59 Million USD | 96.182% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 99.268% |
| IMAC Holdings, Inc. | 5.02 Million USD | 14.474% |
| biote Corp. | 98.82 Million USD | 95.649% |
| Cryo-Cell International, Inc. | 35.2 Million USD | 87.787% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 98.727% |
| COMPASS Pathways plc | 136.91 Million USD | 96.86% |
| DocGo Inc. | 180.32 Million USD | 97.616% |
| The Ensign Group, Inc. | 335.39 Million USD | 98.718% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 97.726% |
| InnovAge Holding Corp. | 558.25 Million USD | 99.23% |
| Assure Holdings Corp. | 15.43 Million USD | 72.152% |
| The Joint Corp. | 109.22 Million USD | 96.064% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 99.125% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | 76.431% |
| ModivCare Inc. | 586.89 Million USD | 99.267% |
| NewGenIvf Group Limited | 1.63 Million USD | -162.238% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | 68.166% |
| Option Care Health, Inc. | 666.62 Million USD | 99.355% |
| P3 Health Partners Inc. | 199.56 Million USD | 97.846% |
| P3 Health Partners Inc. | 199.56 Million USD | 97.846% |
| The Pennant Group, Inc. | 88.99 Million USD | 95.169% |
| Surgery Partners, Inc. | 319.5 Million USD | 98.654% |
| Talkspace, Inc. | 97.58 Million USD | 95.594% |
| Talkspace, Inc. | 97.58 Million USD | 95.594% |
| The Oncology Institute, Inc. | 136.59 Million USD | 96.852% |
| The Oncology Institute, Inc. | 136.59 Million USD | 96.852% |